--- schema_version: "secwatch.filing_event.v1" accession: "0001558370-22-018843" form_type: "8-K" ticker: "HIND" cik: "0001427570" company_name: "Vyome Holdings, Inc" filed_at: "2022-12-20T23:59:59+00:00" generated_at: "2026-06-21T01:40:10.128827+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.65 calibrated_materiality_score: 0.65 confidence: "high" source: SEC EDGAR --- # ReShape Lifesciences shareholders approve 2022 equity plan, reverse split, authorized share increase ## Summary - Stockholders approved 2022 Equity Incentive Plan with 5,250,000 shares available; effective through Dec 13, 2032. - Authorized reverse stock split at ratio 1:30 to 1:100, at Board's discretion, valid until Dec 14, 2023. - Increased authorized common shares to 300,000,000 shares from prior limit. - Elected Paul F. Hickey as Class III director; votes for 5,366,444 vs withheld 580,976. - Ratified RSM US LLP as independent auditor for FY2022; votes for 13,866,558. ## SEC filing metadata - accession: 0001558370-22-018843 - form_type: 8-K - ticker: HIND - cik: 0001427570 - company_name: Vyome Holdings, Inc - filed_at: 2022-12-20T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.65 - calibrated_materiality_score: 0.65 - confidence: high - sec_items: 5.02, 5.07, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/rsls-20221214x8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001558370-22-018843 - JSON: https://secwatch.observer/filing/0001558370-22-018843.json - Plain text: https://secwatch.observer/filing/0001558370-22-018843.txt ## Key facts - Shareholder Votes Vyome Holdings, Inc shareholders approved Amendment to Article IV, Section 1 of the Certificate of Incorporation to increase authorized common stock to 300,000,000 shares at the 2022-12-14 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders approved an amendment to Article IV, Section 1 of the Certificate of Incorporation to increase the number of shares of common stock authorized for issuance to 300,000,000 shares, as set forth below. Votes For Votes Against Abstentions 72,167,316 ​ 17,231,487 ​ 29,146 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - Shareholder Votes Vyome Holdings, Inc shareholders approved Authorization to amend Certificate of Incorporation to effect a reverse stock split at a ratio in the range of 1-for-30 to 1-for-100 at the 2022-12-14 meeting. - Proposal: reverse split - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders authorized the Board, in its discretion but in no event later than December 14, 2023, which is one year after the date of the Annual Meeting, to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock, at a ratio in the range of 1-for-30 to 1-for-100, such ratio to be determined by the Board and included in a public announcement, as set forth below. Votes For Votes Against Abstentions 73,383,162 ​ 13,008,564 ​ 36,223 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - Shareholder Votes Vyome Holdings, Inc shareholders approved Election of Paul F. Hickey as a Class III director at the 2022-12-14 meeting. - Proposal: director election - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders elected Paul F. Hickey as a Class III director to hold office until the 2025 annual meeting of stockholders or until his successor is elected and qualified, or, if sooner, until his death, resignation or removal, as set forth below. Votes For Votes Withheld Broker Non-Votes 5,366,444 ​ 580,976 ​ 8,480,529 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - Shareholder Votes Vyome Holdings, Inc shareholders approved Approval of the ReShape Lifesciences Inc. 2022 Equity Incentive Plan at the 2022-12-14 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders approved the ReShape Lifesciences Inc. 2022 Equity Incentive Plan, as set forth below. Votes For Votes Against Abstentions Broker Non-Votes 3,721,022 ​ 2,142,351 ​ 84,047 ​ 8,480,529 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - Shareholder Votes Vyome Holdings, Inc shareholders approved Ratification of appointment of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2022 at the 2022-12-14 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022, as set forth below. Votes For Votes Against Abstentions 13,866,558 ​ 417,065 ​ 144,326 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm - Shareholder Votes Vyome Holdings, Inc shareholders approved Advisory vote on compensation of named executive officers at the 2022-12-14 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2022-12-14 source text: The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as set forth below. Votes For Votes Against Abstentions Broker Non-Votes 4,054,583 ​ 1,837,687 ​ 55,150 ​ 8,480,529 evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.